These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37325313)

  • 1. Mapping the Peds QL
    Wang Q; Wan C; Li M; Huang Y; Xi X
    Front Public Health; 2023; 11():1166760. PubMed ID: 37325313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychometric Comparison of EQ-5D-Y, CHU-9D, and PedsQL 4.0 in Chinese Children and Adolescents With Functional Dyspepsia: A Multicenter Study.
    He S; Chen L; Wang P; Xi X
    Value Health; 2023 Dec; 26(12):1754-1762. PubMed ID: 37722594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating CHU-9D Utility Scores from the WAItE: A Mapping Algorithm for Economic Evaluation.
    Robinson T; Oluboyede Y
    Value Health; 2019 Feb; 22(2):239-246. PubMed ID: 30711070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping health assessment questionnaire disability index onto EQ-5D-5L in China.
    Wan C; Wang Q; Xu Z; Huang Y; Xi X
    Front Public Health; 2023; 11():1123552. PubMed ID: 37143986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping the Paediatric Quality of Life Inventory (PedsQL™) Generic Core Scales onto the Child Health Utility Index-9 Dimension (CHU-9D) Score for Economic Evaluation in Children.
    Lambe T; Frew E; Ives NJ; Woolley RL; Cummins C; Brettell EA; Barsoum EN; Webb NJA;
    Pharmacoeconomics; 2018 Apr; 36(4):451-465. PubMed ID: 29264866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping PedsQL™ Generic Core Scales to EQ-5D-3L utility scores in transfusion-dependent thalassemia patients.
    Shafie AA; Chhabra IK; Wong JHY; Mohammed NS
    Eur J Health Econ; 2021 Jul; 22(5):735-747. PubMed ID: 33860379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of the SF-6D utility score from Lung cancer FACT-L: a mapping study in China.
    Yang Q; Jiang LL; Li YF; Huang D
    Health Qual Life Outcomes; 2023 Nov; 21(1):122. PubMed ID: 37964348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An assessment of the construct validity of the Child Health Utility 9D-CHN instrument in school-aged children: evidence from a Chinese trial.
    Zanganeh M; Adab P; Li B; Frew E
    Health Qual Life Outcomes; 2021 Aug; 19(1):205. PubMed ID: 34446001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping the Strengths and Difficulties Questionnaire onto the Child Health Utility 9D in a large study of children.
    Sharma R; Gu Y; Sinha K; Aghdaee M; Parkinson B
    Qual Life Res; 2019 Sep; 28(9):2429-2441. PubMed ID: 31154585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping CHU9D Utility Scores from the PedsQL
    Mpundu-Kaambwa C; Chen G; Russo R; Stevens K; Petersen KD; Ratcliffe J
    Pharmacoeconomics; 2017 Apr; 35(4):453-467. PubMed ID: 27928758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of algorithms for estimating the Child Health Utility 9D from Caregiver Priorities and Child Health Index of Life with Disability.
    Tonmukayakul U; Willoughby K; Mihalopoulos C; Reddihough D; Mulhern B; Carter R; Robinson S; Chen G
    Qual Life Res; 2024 Jul; 33(7):1881-1891. PubMed ID: 38700756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the CHU-9D and the EQ-5D-Y instruments in children and young people with cerebral palsy: a cross-sectional study.
    Ryan JM; McKay E; Anokye N; Noorkoiv M; Theis N; Lavelle G
    BMJ Open; 2020 Sep; 10(9):e037089. PubMed ID: 32912983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping the Haem-A-QoL to the EQ-5D-5L in patients with hemophilia.
    Xu RH; Dong D; Luo N; Wong EL; Yang R; Liu J; Yuan H; Zhang S
    Qual Life Res; 2022 May; 31(5):1533-1544. PubMed ID: 34846671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From KIDSCREEN-10 to CHU9D: creating a unique mapping algorithm for application in economic evaluation.
    Chen G; Stevens K; Rowen D; Ratcliffe J
    Health Qual Life Outcomes; 2014 Aug; 12():134. PubMed ID: 25169558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping of the EORTC QLQ-C30 to EQ-5D-5L index in patients with lymphomas.
    Xu RH; Wong ELY; Jin J; Dou Y; Dong D
    Eur J Health Econ; 2020 Dec; 21(9):1363-1373. PubMed ID: 32960388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping EQ-5D utility scores from the PedsQL™ generic core scales.
    Khan KA; Petrou S; Rivero-Arias O; Walters SJ; Boyle SE
    Pharmacoeconomics; 2014 Jul; 32(7):693-706. PubMed ID: 24715604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Converting Parkinson-Specific Scores into Health State Utilities to Assess Cost-Utility Analysis.
    Chen G; Garcia-Gordillo MA; Collado-Mateo D; Del Pozo-Cruz B; Adsuar JC; Cordero-Ferrera JM; Abellán-Perpiñán JM; Sánchez-Martínez FI
    Patient; 2018 Dec; 11(6):665-675. PubMed ID: 29876865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A psychometric investigation of health-related quality of life measures for paediatric neurodevelopment assessment: Reliability and concurrent validity of the PEDS-QL, CHU-9D, and the EQ-5D-Y.
    Perry N; Boulton KA; Hodge A; Ong N; Phillips N; Howard K; Raghunandan R; Silove N; Guastella AJ
    Autism Res; 2024 May; 17(5):972-988. PubMed ID: 38597587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mapping study in mainland China: predicting EQ-5D-5L utility scores from the psoriasis disability index.
    Su J; Liu T; Li S; Zhao Y; Kuang Y
    J Med Econ; 2020 Jul; 23(7):737-743. PubMed ID: 32223358
    [No Abstract]   [Full Text] [Related]  

  • 20. Obtaining SF-6D utilities from FACT-H&N in thyroid carcinoma patients: development and results from a mapping study.
    Yang Q; Huang D; Jiang L; Tang Y; Zeng D
    Front Endocrinol (Lausanne); 2023; 14():1160882. PubMed ID: 37664851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.